Investment and M&A transaction comps
Hair Care Investment & M&A Transaction Comps
Reviewed transaction comps tagged hair care, including disclosed, estimated and rumored values where source notes or calculation basis are available.
8
Reviewed transactions
6
With price data
3.3x
Median EV or valuation / revenue
17.8x
Median EV or valuation / EBITDA
Sortable transaction comps
Hair Care transaction table
Rows with reported value
6 / 8
Acquisition value, USD
USD 1.5B
Investment capital, USD
USD 84.0M
Median EV or valuation / revenue
3.3x
Select up to 12 rows across filters and pages, then share or export the set.
Selected comparison set
Saved in this browser only. Nothing is written to FundComb data.
Choose transactions from the table to build a quick comparison set.
8 shown of 8 matching transactions. Click any transaction row for more detail.
| Select for comparison | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Beautynova Control | 2024-03-18 | PAI Partners | EUR 330M | 365 | 2.5x | 10.6x | Italy | Estimated 1 source | ||
| Straand Capital Raise | 2023-12-10 | Unilever Ventures | USD 4.0M Investment Amount | 4 | - | - | Australia | Confirmed 1 source | ||
| Mielle Organics Control | 2023-01-11 | P&G Beauty | EUR 595M | 639 | 5.6x | 22.0x | - | Confirmed 2 sources | ||
| NAK Hair Control | 2022-05-01 | Adamantem Capital | AUD 90.0M | 65 | 2.3x | - | Australia | Estimated 1 source | ||
| Sol de Janeiro Control (83%) | 2021-11-15 | L'Occitane | USD 450M | 450 | 7.5x | 21.1x | United States | Estimated 3 sources | ||
| Vegamour Minority | 2021-04-13 | General Atlantic | USD 80.0M Investment Amount | 80 | 3.0x | 15.0x | - | Confirmed 1 source | ||
| Every Man Jack Control | 2020-12-01 | The Carlyle Group | Undisclosed Undisclosed | Undisclosed | - | - | United States | Confirmed 1 source | ||
| Viviscal Control | 2017-01-20 | Church & Dwight | Undisclosed | Undisclosed | 3.6x | 17.8x | - | Confirmed 1 source |
FundComb transaction comps are informational only. Values may be estimated, rumored, incomplete or derived from public information and should not be relied upon as financial, investment or valuation advice.